Phase 3 TRIUMPH-4 (December 2025) The first successful Phase 3 readout a 68-week trial in 445 adults with obesity and knee osteoarthritis reported 28.7% mean body weight reduction on the 12mg weekly dose (26.4% on 9mg, 2.1% on placebo)
Novo Nordisk is developing IcoSema, a once-weekly combination of insulin icodec and semaglutide for people with type 2 diabetes
Decision Framework: Questions to Ask Any Provider Rather than identifying a "best" option, individuals considering semaglutide treatment should evaluate their circumstances using these questions: Medical Appropriateness Do I have any contraindications listed in prescribing information
And its easy to see why: Wegovy, the brand name for semaglutide FDA-approved to treat obesity and reduce cardiovascular risk, comes at a high price if insurance doesnt cover it
Discover which foods and dietary supplements contain lead and other metals, the limits, whos testing, and how to stay safe
Increased Nausea: Both GLP-1 agonists and alcohol can irritate the stomach lining, leading to nausea